LifeVantage (NASDAQ: LFVN) discloses CMO and innovation chief exits

Rhea-AI Filing Summary

LifeVantage Corporation disclosed that two senior executives plan to leave the company in December 2025. On December 3, 2025, Chief Marketing Officer Julie Boyster notified the company of her intention to resign from that role effective December 12, 2025 to pursue other business opportunities.

On the same date, Chief Information and Innovation Officer Todd Thompson informed LifeVantage that he intends to resign from his role effective December 24, 2025, also to pursue other business opportunities. These changes affect the leaders overseeing the company’s marketing and information/innovation functions.

Positive

• None.

Negative

• Two senior executives, including the Chief Marketing Officer and Chief Information and Innovation Officer, are resigning from LifeVantage in December 2025 to pursue other business opportunities.

Insights

Corporate governance analyst

Two senior LifeVantage executives are resigning, removing current leadership over marketing and information/innovation functions.

LifeVantage reports that its Chief Marketing Officer, Julie Boyster, plans to resign effective December 12, 2025, and its Chief Information and Innovation Officer, Todd Thompson, plans to resign effective December 24, 2025, both to pursue other business opportunities. These roles are central to how the company manages its brand, customer acquisition and technology or innovation efforts.

Executive changes at this level can alter how marketing strategies and innovation projects are directed and prioritized. The disclosure focuses on the timing and stated reason for the departures, so the ultimate effect on operations and strategy will depend on how LifeVantage reallocates responsibilities and fills these leadership positions.

0000849146false00008491462025-12-032025-12-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 ______________________________

 FORM 8-K

 ______________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 3, 2025

 ______________________________

LIFEVANTAGE CORPORATION

(Exact name of registrant as specified in its charter)

______________________________

Delaware

001-35647

90-0224471

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(IRS Employer Identification No.)

3300 Triumph Blvd, Suite 700

Lehi, Utah 84043

(Address of principal executive offices, including zip code)

(801) 432-9000

(Registrant's telephone number)

_____________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, par value $0.0001

LFVN

The Nasdaq Stock Market LLC

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 3, 2025, Julie Boyster, the Chief Marketing Officer of LifeVantage Corporation (the “Company”), notified the Company of her intention to resign from such role, effective December 12, 2025, to pursue other business opportunities.

Also on December 3, 2025, Todd Thompson, the Chief Information and Innovation Officer of the Company, notified the Company of his intention to resign from such role, effective December 24, 2025, to pursue other business opportunities.

SIGNATURE

Date:			December 8, 2025			LIFEVANTAGE CORPORATION
			By:			/s/ Steven R. Fife
			Name:			Steven R. Fife
			Title:			President and Chief Executive Officer

FAQ

What leadership changes did LifeVantage (LFVN) disclose?

LifeVantage disclosed that its Chief Marketing Officer, Julie Boyster, and its Chief Information and Innovation Officer, Todd Thompson, each notified the company of their intention to resign from those roles.

When will LifeVantage's Chief Marketing Officer resign?

Chief Marketing Officer Julie Boyster informed LifeVantage that her resignation from that role will be effective on December 12, 2025.

When will LifeVantage's Chief Information and Innovation Officer resign?

Chief Information and Innovation Officer Todd Thompson informed LifeVantage that his resignation from that role will be effective on December 24, 2025.

What reason is given for the LifeVantage executive resignations?

Both Julie Boyster and Todd Thompson are resigning from their respective roles at LifeVantage to pursue other business opportunities, according to the company.

Which roles at LifeVantage (LFVN) are affected by these resignations?

The resignations affect LifeVantage's Chief Marketing Officer position and its Chief Information and Innovation Officer position.